Walid Khalbuss

Report 5 Downloads 72 Views
VMT2

Current Diagnostic Challenges in Lung FNA Walid E Khalbuss, MD PhD FIAC Professor of Pathology & Director of Cytology University of Pittsburgh Medical Center (UPMC)

[email protected]

Speaker Disclosure In the past 12 months, months I have not had a significant financial interest or other relationship with the manufacturer(s) of the product(s) or provider(s) of the service(s) that will be disc ssed in my discussed m presentation. presentation

Walid Khalbuss

Diagnosis of Lung Cancer in Small Biopsies and Cytology Implications of the 2011 International Association for the Study of Lung Cancer/ American Thoracic Society/European Respiratory Society Classification. Travis et al, Arch Pathol Lab Med. 2012;136:1–17.

Yoshizawa et al, 2011

Do more with less tissue NSCLC & EBUS/EUS FNA Common & Important Dx

70% of f NSCLCs NSCLC are unrespectable t bl att presentation t ti  many Dx’s made based on cytology Evaluation: morphology, IHC, molecular

Important to subtype for selection of appropriate treatment

Sigel CS et al, J Thorac Oncol 2011

S b l ifi i of Sub-classification f NSCLC Cytology superior for morphology & subclassification

Better nuclear & cytoplasmic detail Less fixation artifact

Morphology

AdenoCa: prominent nucleoli, vacuolated cytoplasm; glands and strips on CB SqCC: dense cytoplasm cytoplasm, more pleomorphism, pleomorphism coarse chromatin; 2D syncytial groups with keratin pearls and intercellular bridges

Sigel CS et al, J Thorac Oncol 2011

Sub-Classification of NSCLC • Accurate sub-classification of NSCLC and acquisition of sufficient material for molecular studies is crucial. • Balancing the need of adequate material for accurate diagnosis with the demands of clinicians to do more with less tissue has been a challenge and continues to impact the way lung cancers are approached in cytopathology.

Comparison of lung diagnosis in the past and i cytomorphology t h l presentt using Treatment g Surgical: NSCLC Non-surgical: SCC





Need for subtyping and molecular studies Theranostic data Monaco, 2012

IHC

NSCLC FNA

AdenoCa: +CK7, +CK7 +TTF1 (+NapsinA) SqCC: +p63/p40 (+Glypican3, +CK5/6) Other: Synaptophysin p40

TTF1-Napsin A

TTF1

p40-CK5

p40-CK5

Molecular Testing g in NSCLC FNA Cases EGFR sequencing KRAS sequencing BRAF sequencing FISH for ALK FISH for FGFR1

Monaco, 2012

Conserving Tissue in Lung Ca Cases 26 Unstained slides on char charged ed slides Number slides in order when cutting Triage Blank #

Triage

1

H&E to case p pathologist g

2

H&E to FISH & Molecular Labs

3, 4, 5 6

First 3 IHC markers

(i.e. TTF-1, CK5/6 or p63/p40)

H&E to t case pathologist th l i t (deeper (d llevel) l)

7-15

Blanks to Molecular Lab

16-21

Blanks to FISH Lab

22-25

Blanks for additional testing (e.g. additional IHC)

26

Negative control for IHC

EBUS: +NSCLC 2 extra passes for cell block

S Squamous C Cell ll Carcinoma C i • • • • • • • • • • • • • • • • • • • •

More central (67%), males >50 yrs, now upper lobes. A geographic hi Sheets Sh t (2 (2-D); D) or single i l large l cells ll Pleomorphic cells, bizarre cells, Variable Keratinization (deep cytoplasmic orangophilia, or yellow/degenerative). Cytoplasmic rings (Herxheimer spirals), thickness with refractivity. Intercellular bridges (cell block better); gaps between cells Poorly differentiated have high N/C ratio and less or no keratinization Dense cytoplasm/glassy appearance/ cytoplasmic endocytoplasmic ringing p well defined cytoplasmic p borders. Sharp Can have cytoplasmic vacuolization. Peripheral and/or central nuclear spindling is usually appreciated. The nuclei tend to be central, hyperchromatic, pleomorphic and smudgy. n rma c coarse ar chr chromatin mat n clumping, c ump ng, para para-chromatin chr mat n clearing. c ar ng. Abnormal Small or macro-nucleolie. In high grade (non keratinizing ca), nuclei are more vesicular. Tadpole cell shapes (with other features of malignancies) Ghost cells Necrotic or inflammatory or rarely tigroid background Sometimes impossible to sub-classify PD squamous ca without immuno (CK5/6+, p40+,TTF1-) 84% are EGFR positive; KRAS, very rare

Squamous q Cell Carcinoma- Challenges g • Well-preserved malignant cells may be difficult • Single cells exhibiting squamous differentiation. • Syncytial tissue fragments without any architectural patterns. • Very pleomorphic dyskeratoic squamous cells. • Papillary or verrucous type, basaloid; Small cell, and clear cell variant • Small degenerating squamous cells aka pap cells.

Squamous Cell Ca- Grade/Subtype

Papillary variant

Squamous Papilloma

Well-differentiated

Moderately-differentiated

1.Squamous Papilloma

2. Keratinizing Squamous Ca

basaloid variant

Poorly-differentiated

3. Non-Keratinizing Squamous Ca

4. Clear cell Variant

5. Basaloid Variant

Acinar

Papillary

Micropapillary

Solid

Adenocarcinoma in Situ (